Balla v. Gambro, Inc.

560 N.E.2d 1043, 203 Ill. App. 3d 57, 5 I.E.R. Cas. (BNA) 1218, 148 Ill. Dec. 446, 1990 Ill. App. LEXIS 1376
CourtAppellate Court of Illinois
DecidedSeptember 10, 1990
DocketNo. 1-88-2955
StatusPublished
Cited by1 cases

This text of 560 N.E.2d 1043 (Balla v. Gambro, Inc.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Balla v. Gambro, Inc., 560 N.E.2d 1043, 203 Ill. App. 3d 57, 5 I.E.R. Cas. (BNA) 1218, 148 Ill. Dec. 446, 1990 Ill. App. LEXIS 1376 (Ill. Ct. App. 1990).

Opinion

JUSTICE O’CONNOR delivered the opinion of the court:

Roger J. Balia (Balia),

an attorney, sued his previous employer, Gambro, Inc. (Gambro); its affiliate, Gambro Dialysatoren, KG (Gambro Germany); Gambro’s corporate parent, Gambro Lundia, AB (Gambro Sweden); and Gambro’s president, David Maupin (Maupin), alleging retaliatory discharge. The trial court entered summary judgment for Gambro et al, holding that since Balia was an attorney, he was barred from bringing a retaliatory discharge claim. Balia appeals.

Gambro is a distributor of kidney dialysis equipment manufactured by Gambro Germany. Among the products manufactured and distributed are dialyzers, which filter excess fluid and toxic substances from the blood of patients with impaired or no kidney function. The manufacture and sale of dialyzers is regulated by the United States Food and Drug Administration (FDA) under the United States Food, Drug and Cosmetic Act (Act), 21 U.S.C. §331 et seq. (1988), and FDA regulations, 21 C.F.R. §§820.150 through 820.198 (1987).

Gambro hired Balia in March 1980, as manager of personnel and general counsel. According to Gambro’s 1983 corporate organization chart, Balia also held the position of manager of regulatory affairs.1 The position of manager of regulatory affairs was described as an individual who was “responsible for ensuring awareness of and compliance with federal, state and local laws and regulations affecting the company’s operations and products.” The position required a “B.S. degree plus 3-5 years experience in the medical device field plus 2 years experience in the area of governmental regulations.”

By letter dated July 1985, Gambro Germany informed Gambro that defective dialyzers would be shipped. Gambro Germany further advised Gambro:

“For acute patients risk is that the acute uremic situation will not be improved in spite of the treatment, giving continuous high levels of potassium, phosphate and urea/creatine. The [chronic] patient may note the effect as a slow progression of the uremic situation and depending on the interval between medical check-ups the medical risk may not be overlooked.” (Emphasis added.)

At this time, Balia alleges that he informed Maupin that Gambro’s sale of these dialyzers would have to be reported to the FDA.

Nevertheless, in a telex dated July 19, 1985, Maupin informed Gambro that “[w]e [Gambro] are going to sell the *** [defective dialyzers] to a unit that is not currently our customer but who buys only on price.” In August 1985, the dialyzers arrived at Gambro’s facility. In Balia’s deposition, he stated that as an individual as well as an attorney, he was of the opinion that “the dialyzers were misbranded and/or adulterated.”

On September 4, 1985, Maupin terminated Balia from Gambro’s employment. Later that day, Gambro shipped some of the defective dialyzers to customers. On September 5, 1985, Balia reported the defective shipment to the FDA. The FDA seized the shipment and determined the product to be “adulterated within the meaning of section 501(h) [of the Food, Drug, and Cosmetic Act].”

Subsequently, Balia filed his complaint alleging retaliatory discharge and seeking monetary damages. Initially, the trial court dismissed the action against Maupin, Gambro Sweden, and Gambro Germany. Then, the court granted Gambro’s summary judgment motion, holding that Balia’s complaint failed to state a cause of action pursuant to Herbster v. Northern American Co. for Life & Health Insurance (1986), 150 Ill. App. 3d 21, 501 N.E.2d 343, appeal denied (1987), 114 Ill. 2d 545, 508 N.E.2d 728, cert, denied (1987), 484 U.S. 850, 98 L. Ed. 2d 105, 108 S. Ct. 150, because Balia was an attorney. Balia appeals.

Balia argues that he was standing to bring a cause of action for retaliatory discharge, notwithstanding the Herbster decision. We agree. Retaliatory discharge is an exception to the general rule that an at-will employment relationship may be terminated at any time for any or no cause. Notwithstanding the at-will employment relationship, the law recognizes a cause of action when it is alleged that the employee was discharged in retaliation for his activities, and that the discharge was in contravention of a clearly mandated public policy. (Wheeler v. Caterpillar Tractor Co. (1985), 108 Ill. 2d 502, 505, 485 N.E.2d 372, cert, denied (1986), 475 U.S. 1122, 90 L. Ed. 2d 187, 106 S. Ct. 1641; Palmateer v. International Harvester Co. (1981), 85 Ill. 2d 124, 134, 421 N.E.2d 876.) Accordingly, Balia has alleged that he was discharged because he opposed the distribution of allegedly “misbranded and/or adulterated dialyzers” and that his discharge contravenes public policy.

Public policy clearly favors the prevention of interstate and intrastate distribution of “misbranded and/or adulterated dialyzers.” This public policy is exemplified by Federal and State statutes which criminalize the distribution of defective dialyzers. (21 U.S.C. §331 et seq. (1988); Ill. Rev. Stat. 1987, ch. 56V2, par. 501 et seq.) Moreover, “[t]here is no public policy more important *** than the one favoring the effective protection of the lives and property of citizens.” (Wheeler v. Caterpillar Tractor Co. (1985), 108 Ill. 2d 502, 511, 485 N.E.2d 372, cert, denied (1986), 475 U.S. 1122, 90 L. Ed. 2d 187, 106 S. Ct. 1641; Palmateer v. International Harvester Co. (1981), 85 Ill. 2d at 132, 421 N.E.2d at 876.) Therefore, Balia clearly alleged two public policies that support that his termination was wrongful: (1) a public policy which favors his refusal to engage in Gambro’s alleged illegal activities; and (2) a public policy which favors the protection of citizens’ lives by opposing the distribution of allegedly “misbranded and/or adulterated dialyzers.”

If Balia had been a layman-employee rather than an attorney-employee, there would be no question as to his standing to bring a cause of action for retaliatory discharge. However, because Balia was Gambro’s in-house counsel and held several positions with Gambro, the question of standing becomes less obvious because we must consider the nature and sanctity of the attorney/client relationship. Some courts have refused to grant attorneys standing in a retaliatory discharge action fearing that the attorneys would breach their fiduciary duty by disclosing their client’s confidential information and fearing that clients would not be able to terminate their attorney at any time. The issue of whether Balia has standing to bring a cause of action for retaliatory discharge turns on the outcome of the following three-part analysis.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Balla v. Gambro, Inc.
560 N.E.2d 1043 (Appellate Court of Illinois, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
560 N.E.2d 1043, 203 Ill. App. 3d 57, 5 I.E.R. Cas. (BNA) 1218, 148 Ill. Dec. 446, 1990 Ill. App. LEXIS 1376, Counsel Stack Legal Research, https://law.counselstack.com/opinion/balla-v-gambro-inc-illappct-1990.